The major goal of this Program Project Grant (PPG) is to continue to expand and further develop a vigorous research program focused on elucidating the etiology and pathogenesis of frontotemporal dementias (FTDs) tauopathies and other neurodegenerative variants of FTDs. During the last funding cycle, a close-knit and highly integrated multidisciplinary group of investigators formed a productive collaborative alliance and established a very comprehensive clinical and basic science research center-without-walls to study patients with FTDs. During the next funding period of this PPG, these seasoned investigators and young faculty newly recruited to the PPG propose a set of bold new objectives for FTD research that will be implemented through 3 Cores and 4 Projects. Specifically, they will characterize the spectrum of the clinical phenotypes seen in FTD patients, identify new mutations in FTD kindreds, elucidate mechanism of tau fibrillization, determine the building blocks ofubiquitin positive but tau, alpha-synuclein and neurofilament negative inclusions in FTD with or without motor neuron disease, and develop transgenic mouse and Co elegans models with greater versimilitude to human tau pathologies thereby leading to improvements in understanding FTDs as well as the diagnosis and treatment of these disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG017586-06
Application #
6850950
Study Section
Special Emphasis Panel (ZAG1-ZIJ-9 (O4))
Program Officer
Snyder, Stephen D
Project Start
2000-03-15
Project End
2010-02-28
Budget Start
2005-04-01
Budget End
2006-02-28
Support Year
6
Fiscal Year
2005
Total Cost
$1,600,093
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Sanchez-Contreras, Monica Y; Kouri, Naomi; Cook, Casey N et al. (2018) Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci. Mol Neurodegener 13:37
Robinson, John L; Corrada, Maria M; Kovacs, Gabor G et al. (2018) Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+ Study. Acta Neuropathol :
Brettschneider, Johannes; Suh, EunRan; Robinson, John L et al. (2018) Converging Patterns of ?-Synuclein Pathology in Multiple System Atrophy. J Neuropathol Exp Neurol 77:1005-1016
Suh, EunRan; Grando, Kaitlyn; Van Deerlin, Vivianna M (2018) Validation of a Long-Read PCR Assay for Sensitive Detection and Sizing of C9orf72 Hexanucleotide Repeat Expansions. J Mol Diagn 20:871-882
Zee, Jarcy; Xie, Sharon X (2018) The Kaplan-Meier Method for Estimating and Comparing Proportions in a Randomized Controlled Trial with Dropouts. Biostat Epidemiol 2:23-33
Oukoloff, Killian; Kovalevich, Jane; Cornec, Anne-Sophie et al. (2018) Design, synthesis and evaluation of photoactivatable derivatives of microtubule (MT)-active [1,2,4]triazolo[1,5-a]pyrimidines. Bioorg Med Chem Lett 28:2180-2183
Phillips, Jeffrey S; Das, Sandhitsu R; McMillan, Corey T et al. (2018) Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease. Hum Brain Mapp 39:691-708
Smith, Kara M; Ash, Sharon; Xie, Sharon X et al. (2018) Evaluation of Linguistic Markers of Word-Finding Difficulty and Cognition in Parkinson's Disease. J Speech Lang Hear Res 61:1691-1699
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Gangishetti, Umesh; Christina Howell, J; Perrin, Richard J et al. (2018) Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimers Res Ther 10:98

Showing the most recent 10 out of 593 publications